<?xml version="1.0" encoding="UTF-8"?>
<p>Presence of one or more fluorine atoms can be seen in a range of drugs used for different disorders including the antibacterials: fluoroquinolones; antifungal: fluconazole; antivirals: efavirenz, trifluridine; anticancer agents: 5-fluorouracil, bicalutamide, leflunomide; antifungals: 5-flucytosine; antidepressants: fluoxetine, escitalopram; steroids: dexamethasone, triamcinolone, fludrocortisone; selective COX-II inhibitors: celecoxib; antiulcer: lansoprazole; antihyperlipidemic agents: atorvastatin, rosuvastatin, ezetimibe, and an antischizophrenic agent: risperidone (
 <xref ref-type="fig" rid="pharmaceuticals-13-00375-f002">Figure 2</xref>). The presence of fluorine atoms in the medicinally active compounds have imparted some special properties, including increased binding interactions, potency, permeability, metabolic stability, decreased 
 <italic>pka</italic>, clearance, alteration of the conformation, modified physical properties, and selective reactivities [
 <xref rid="B31-pharmaceuticals-13-00375" ref-type="bibr">31</xref>,
 <xref rid="B32-pharmaceuticals-13-00375" ref-type="bibr">32</xref>,
 <xref rid="B33-pharmaceuticals-13-00375" ref-type="bibr">33</xref>,
 <xref rid="B34-pharmaceuticals-13-00375" ref-type="bibr">34</xref>,
 <xref rid="B35-pharmaceuticals-13-00375" ref-type="bibr">35</xref>].
</p>
